Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America.
Mariano B, Hamerschlak N, Vera M, Belén C, Andrés GP, Gonzalo F, José RJ, Adriana V, Alberto GC, Georgina B, Sebastián Y, Juliana MR, Martin S, Sol J, Amalia C, Cinthya CDS, Morgani R, Leandro R, Jorge A, Gustavo K, Lisa BA; GATMO-TC: Grupo Argentino de Trasplante de Medula Osea y Terapia Celular.
Mariano B, et al. Among authors: alberto gc.
Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):330-336. doi: 10.56875/2589-0646.1042.
Hematol Oncol Stem Cell Ther. 2023.
PMID: 37363982